Treatment of Acute Respiratory Distress Syndrome by T Regulatory Cells

摘要

Described are means, methods and compositions of matter for treatment of acute respiratory distress syndrome (ARDS) by enhancement of T regulatory (Treg) number and/or efficacy. In one embodiment of the invention, exogenous Tregs are administered. In another embodiment, enhanced endogenous Tregs are provided using methods including administration of low dose interleukin-2, administration of other cytokines, and administration of cells which stimulate Treg generation such as mesenchymal stem cells.